- Home
- SLS vs ELMD Comparison
SLS vs ELMD Comparison
Compare SLS & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- ELMD
- Stock Information
- Founded
- SLS 2012
- ELMD 1992
- Country
- SLS United States
- ELMD United States
- Employees
- SLS N/A
- ELMD N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SLS Health Care
- ELMD Health Care
- Exchange
- SLS Nasdaq
- ELMD Nasdaq
- Market Cap
- SLS 238.7M
- ELMD 206.6M
- IPO Year
- SLS N/A
- ELMD 2010
- Fundamental
- Price
- SLS $1.92
- ELMD $24.49
- Analyst Decision
- SLS Strong Buy
- ELMD Strong Buy
- Analyst Count
- SLS 1
- ELMD 2
- Target Price
- SLS $7.00
- ELMD $35.50
- AVG Volume (30 Days)
- SLS 4.7M
- ELMD 41.1K
- Earning Date
- SLS 11-12-2025
- ELMD 11-11-2025
- Dividend Yield
- SLS N/A
- ELMD N/A
- EPS Growth
- SLS N/A
- ELMD 46.55
- EPS
- SLS N/A
- ELMD 0.85
- Revenue
- SLS N/A
- ELMD $64,000,000.00
- Revenue This Year
- SLS N/A
- ELMD $14.47
- Revenue Next Year
- SLS N/A
- ELMD $10.33
- P/E Ratio
- SLS N/A
- ELMD $28.81
- Revenue Growth
- SLS N/A
- ELMD 16.97
- 52 Week Low
- SLS $0.77
- ELMD $17.73
- 52 Week High
- SLS $2.48
- ELMD $35.56
- Technical
- Relative Strength Index (RSI)
- SLS 51.34
- ELMD 51.29
- Support Level
- SLS $1.86
- ELMD $24.19
- Resistance Level
- SLS $2.06
- ELMD $24.98
- Average True Range (ATR)
- SLS 0.16
- ELMD 0.69
- MACD
- SLS -0.02
- ELMD -0.11
- Stochastic Oscillator
- SLS 11.90
- ELMD 41.67
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.